Parma, Italy

Stefano Luca Giaffreda

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Chiesi Farmaceutici S.p.a.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stefano Luca Giaffreda. Retrieved from https://idiyas.com/inventor/stefano-luca-giaffreda-90tpbltv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Stefano Luca Giaffreda

Introduction

Stefano Luca Giaffreda is a notable inventor based in Parma, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds aimed at treating serious health conditions.

Latest Patents

Giaffreda holds a patent for "Polymorphs and salts - Novel polymorphic forms and salts of 1-(3',4′-dichloro-2-fluorobiphenyl-4-yl)cyclopropanecarboxylic acid." This invention is particularly important for the prevention or treatment of Alzheimer's Disease. His innovative approach in this area showcases his commitment to addressing critical health challenges.

Career Highlights

Stefano works at Chiesi Farmaceutici S.p.A., a well-respected pharmaceutical company. His role there has allowed him to focus on research and development, contributing to the advancement of medical science through his inventions.

Collaborations

Throughout his career, Giaffreda has collaborated with esteemed colleagues such as Fausto Pivetti and Maurizio Delcanale. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic solutions.

Conclusion

Stefano Luca Giaffreda's work exemplifies the impact of innovative thinking in the pharmaceutical industry. His contributions, particularly in the realm of Alzheimer's treatment, highlight the importance of research and collaboration in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…